Immunicum’s ilixadencel successful in kidney cancer
The drug achieved complete tumour responses in five out of 45 metastatic kidney cancer patients, compared to one in 25.
Read More
Tag: Immunicum
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
